News Information

The "Guangdong-Hong Kong-Macao Traditional Chinese Medicine Anti-Tumor Industry-Academia-Research Deep Integration Summit Forum" and the "Seminar on Traditional Chinese Medicine for Liver Cancer - Sanjie Pian" were grandly held.


Release time:

2020-05-20

1

On December 27, 2019, in response to President Xi Jinping's call to 'inherit the essence, uphold integrity and innovation, accelerate the modernization and industrialization of traditional Chinese medicine, and promote the development of traditional Chinese medicine in the Guangdong-Hong Kong-Macao Greater Bay Area', Zhuhai Miditech Biopharmaceutical Co., Ltd. invited experts including Academician Chen Jinqiu from Hong Kong to hold the 'Guangdong-Hong Kong-Macao Traditional Chinese Medicine Anti-Tumor Industry-Academia-Research Deep Integration Summit Forum' and the 'Traditional Chinese Medicine for Liver Cancer - Sanjie Tablets Seminar' in Zhuhai.

1

Academician Chen Jinqiu and Miditech Chairman Wu Xiukun pose for a photo at the Traditional Chinese Medicine Anti-Tumor Base

1

Miditech Chairman Wu Xiukun and Academician Chen Jinqiu pose for a photo at the summit forum

1

Director of the Interventional Department of Zhuhai People's Hospital Li Yong, Miditech Chairman Wu Xiukun, Academician Chen Jinqiu, and inventor of the Sanjie Tablets Liu Jinfang pose for a photo

1

Miditech Chairman Wu Xiukun poses for a photo with Professor Sun Zhiyong from Zunyi Medical University

1

Chairman Huang Jintang of Hong Kong Jinlun poses for a photo with Miditech Chairman Wu Xiukun

1

Miditech Chairman Wu Xiukun poses for a photo with Secretary-General Yang Shanhong of Zhuhai Pharmaceutical Association

1

Representative of the Jinwan District People's Government poses for a photo with Miditech Chairman

1

Director Li Yong, Academician Chen Jinqiu, and inventor Liu Jinfang pose for a photo

1

Chairman Wu Xiukun, Academician Chen Jinqiu, and inventor Liu Jinfang pose for a photo

1

1

1

Academician Chen Jinqiu, accompanied by Chairman Wu Xiukun, visits the Miditech Traditional Chinese Medicine Anti-Tumor Base factory area (Traditional Chinese Medicine extraction workshop, solid preparation workshop, special medical food production base)

1

 Academician Chen Jinqiu, Director of the Interventional Department of Zhuhai People's Hospital Li Yong, Chairman Huang Jintang of Hong Kong Jinlun, and others visit the Miditech R&D laboratory 

1

1

1

1

1

1

1

1

1

1

1

1

Group photo of the academician expert team

1

Miditech Chairman Wu Xiukun poses for a photo with investor Mr. He and others

1

1

1

1

1

Chairman's welcome speech at Zhuhai Miditech Biopharmaceutical Co., Ltd.

(Summary of the welcome speech)

With the continuous advancement of the construction of the Guangdong-Hong Kong-Macao Greater Bay Area, and on the occasion of the completion of the Guangdong-Macao Traditional Chinese Medicine Industrial Park in the Hengqin Free Trade Zone of Zhuhai, the 2019 document 'Opinions of the Central Committee of the Communist Party of China and the State Council on Promoting the Inheritance and Innovation of Traditional Chinese Medicine' was released, placing traditional Chinese medicine in an important position in national strategy, incorporating it into the construction of a community with a shared future for mankind and the important content of the Belt and Road international cooperation, and creating a highland for traditional Chinese medicine in the Guangdong-Hong Kong-Macao Greater Bay Area. Traditional Chinese medicine is ushering in significant development opportunities with favorable timing, geographical advantages, and harmonious relationships. Under this favorable situation, the 'Guangdong-Hong Kong-Macao Traditional Chinese Medicine Anti-Tumor Industry-Academia-Research Deep Integration Summit Forum and the Traditional Chinese Medicine for Liver Cancer - Sanjie Tablets Seminar' was successfully held.

This conference invited top experts in traditional Chinese medicine, including Academician Chen Jinqiu, Professor Yao Yunshen, Professor Li Zhongji, Director Li Yong, Master Guo Yong, Director Liu Jinfang, Chairman He Xueming from the financial investment field, Chairman Huang Jintang from Hong Kong Jinlun, Professor Sun Zhiyong from Zunyi Medical University, Section Chief Wen Zhihua from the Zhuhai Market Supervision Administration, Section Chief Zhang Hanming from the Zhuhai Science and Technology Innovation Bureau, Section Chief Yan Pengfei from the Jinwan Branch of the Zhuhai Natural Resources Bureau, Director Lu Quanyu from Guangdong Haihui Investment Company, and Secretary-General Yang Shanhong from the Zhuhai Pharmaceutical Association, among other experts and leaders. Everyone gathered to provide insights for Miditech and strategize for the development of traditional Chinese medicine in China.
Traditional Chinese medicine is effective against tumors, eliminating tumors, and promoting a healthy China. Let us work together to create a healthy and beautiful China.

1

Chairman Wu Xiukun awards the appointment letter: Academician Chen Jinqiu's workstation, and Chen Jinqiu as an advisor to Zhuhai Miditech Biopharmaceutical Co., Ltd.

1

Chairman Wu Xiukun awards the appointment letter: Professor Li Zhongji as the chief researcher of the Herbal Quantum Science Research Institute

Miditech Chairman Wu Xiukun introduces the company profile

 
Zhuhai Miditech Biopharmaceutical is a high-tech enterprise dedicated to building a unique pure traditional Chinese medicine anti-tumor base in the country. Currently, the new drug for liver cancer and liver cirrhosis - Sanjie Tablets has obtained the new drug registration certificate from the National Medical Products Administration and has been launched in the market since 2019; the exclusive patented product for lung cancer and nasopharyngeal cancer - Baishan Tablets has obtained clinical approval and is currently undergoing phase I clinical trials; and traditional Chinese medicine varieties for breast cancer, stomach cancer, colon cancer, cervical cancer, etc. are being prepared for application.
Sanjie Tablets are a new type of drug invented and innovated by Director Liu Jinfang (former director of the oncology department of the 202 Hospital of the People's Liberation Army), primarily used for primary liver cancer.
The company has initially formed a closed-loop ecological industrial chain centered on traditional Chinese medicine anti-tumor, supplemented by special medical foods and traditional Chinese medicine pieces, integrating research and development, planting, production, sales, and tumor rehabilitation networks, gradually achieving the grand goal of 'eliminating tumors and promoting a healthy China'.
1
Miditech Traditional Chinese Medicine Anti-Tumor Base
1
Traditional Chinese Medicine for Liver Cancer Sanjie Tablets (launched in 2019)
1
1.
1
1
1
1
Zhang Hanming, Section Chief of Zhuhai Science and Technology Innovation Bureau, delivers a speech on 'Introduction to Zhuhai's Science and Technology Innovation Policies'
1
1
Academician Chen Jinqiu delivers a speech on 'The Role of Traditional Chinese Medicine in Cancer Treatment'
1
Inventor Liu Jinfang delivers a speech on 'Research on Sanjie Tablets for Liver Cancer'
1
Professor Yao Yunshen delivers a speech on 'Fermentation of Medicinal Fungi and Quantum Science onEnhancing the Efficacy of Modern Traditional Chinese Medicine'
1
Master Guo Yong delivers a speech on 'A Few Views on Traditional Chinese Medicine for Liver Cancer'
1
Chief Researcher Li Zhongji of the Herbal Quantum Science Research Institute delivers a speech on 'Research on the 'Super High Energy Ecological Water' and its 'Positive Biological Effects' on the Human Body'
1
Signing ceremony for the cooperation project between Zhuhai Miditech and Academician Chen Jinqiu
1
Signing ceremony for the cooperation project between Zhuhai Miditech and Director Li Yong of the Interventional Department of Zhuhai People's Hospital
1
Signing ceremony of the cooperation project between Zhuhai Miditech and Professor Sun Zhiyong from Zunyi Medical University.
1
Signing ceremony of the cooperation project between Zhuhai Miditech and Master Guo Yong, a traditional Chinese medicine expert.
1
Signing ceremony of the cooperation project between Zhuhai Miditech and quantum expert Li Zhongji.
1
Traditional Chinese Medicine for Liver Cancer - Sanjie Tablets Seminar

1

Traditional Chinese Medicine for Liver Cancer - Sanjie Tablets Seminar

1

Traditional Chinese Medicine for Liver Cancer - Sanjie Tablets Seminar

1

Traditional Chinese Medicine for Liver Cancer - Sanjie Tablets Seminar

1

Traditional Chinese Medicine for Liver Cancer - Sanjie Tablets Seminar

1

Traditional Chinese Medicine for Liver Cancer - Sanjie Tablets Seminar

1

Traditional Chinese Medicine for Liver Cancer - Sanjie Tablets Seminar

Traditional Chinese Medicine for Liver Cancer - Sanjie Tablets Seminar

Traditional Chinese Medicine for Liver Cancer - Sanjie Tablets Seminar

This conference received strong support from the Zhuhai Municipal Science and Technology Innovation Bureau, the Zhuhai Municipal Market Supervision Administration, and the Zhuhai Pharmaceutical Association, and was a great success.

Related Information

Anti-liver cancer and liver cirrhosis traditional Chinese medicine - Sanjie Pian, safeguarding 447 million chronic liver disease patients.

Traditional Chinese Medicine for Liver Cancer and Liver Cirrhosis - Sanjie Pian, safeguarding 447 million chronic liver disease patients.

See more →

The research and development achievements of the anti-liver cancer traditional Chinese medicine - Sanjie Pian have been included in the "National Science and Technology Achievements Database."

In 2021, the anti-liver cancer traditional Chinese medicine - Sanjie Pian passed the expert review by the Ministry of Science and Technology, achieving a level of technological advancement that is considered leading in the country. The research and development results have been included in the National Science and Technology Achievements Database (No. 6012021Y0389). It was publicly announced on the National Science and Technology Achievements Registration Work Platform (Guokewang) in March 2022.

See more →